Pharmacodynamic target

AA Alan Abdulla
OR Omar Rogouti
NH Nicole G. M. Hunfeld
HE Henrik Endeman
AD Annemieke Dijkstra
TG Teun van Gelder
AM Anouk E. Muller
BW Brenda C. M. de Winter
BK Birgit C. P. Koch
request Request a Protocol
ask Ask a question
Favorite

To calculate the ƒAUC0–24/MIC and ƒCmax/MIC ratios, the clinical breakpoint of 0.5 mg/L from the EUCAST database was used [34]. This is the highest MIC from which it can be expected that ciprofloxacin under standard conditions is effective for Enterobacteriaceae, Pseudomonas spp., Acinetobacter spp., Haemophilus influenzae, Moraxella catarrhalis, and Neisseria spp. [34]. To assess the suitability of the empirical fixed dosing regimens considering ƒAUC0–24/MIC ≥ 100 and ƒCmax/MIC ≥ 8, a MIC distribution of 0.0312–8 mg/L was tested. For the targeted treatment at different MICs, the wild-type population distribution of Pseudomonas aeruginosa and the epidemiological cut-off (ECOFF) value from the EUCAST database were used [34].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A